These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17022688)

  • 1. Rapid and direct quantitative RT-PCR method to measure promoter activity.
    Yu L; Domann FE
    Biotechnol Prog; 2006; 22(5):1461-3. PubMed ID: 17022688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
    Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
    Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].
    Li J; Liu Y; Dai JZ; Xu DP; Zhang LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.
    Potratz JC; Mlody B; Berdel WE; Serve H; Müller-Tidow C
    Int J Oncol; 2005 Feb; 26(2):493-8. PubMed ID: 15645135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of a reporter system for fine quantitative assessment of activity of p53 protein in cultured cells].
    Strunina SM; Ivanov AV; Chumakov PM
    Mol Biol (Mosk); 2003; 37(6):1007-18. PubMed ID: 14714496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
    Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
    J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
    Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
    Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells.
    Saffari M; Dinehkabodi OS; Ghaffari SH; Modarressi MH; Mansouri F; Heidari M
    Cancer Lett; 2009 Jan; 273(2):316-22. PubMed ID: 18814959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pCLPG: a p53-driven retroviral system.
    Strauss BE; Costanzi-Strauss E
    Virology; 2004 Apr; 321(2):165-72. PubMed ID: 15051377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting and quantifying p53 isoforms at mRNA level in cell lines and tissues.
    Khoury MP; Marcel V; Fernandes K; Diot A; Lane DP; Bourdon JC
    Methods Mol Biol; 2013; 962():1-14. PubMed ID: 23150433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of flotillin-2, a major protein on lipid rafts, as a novel target of p53 family members.
    Sasaki Y; Oshima Y; Koyama R; Maruyama R; Akashi H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
    Mol Cancer Res; 2008 Mar; 6(3):395-406. PubMed ID: 18296650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
    Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
    J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of transcriptional activities of heterologous promoters in the rare actinomycete Actinoplanes friuliensis.
    Wagner N; Osswald C; Biener R; Schwartz D
    J Biotechnol; 2009 Jul; 142(3-4):200-4. PubMed ID: 19464328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.